Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Patient Focus

Sponsored by

Finalist

T1DStars Website

Sanofi Diabetes in association with Havas Life Medicom


Summary of work

A huge unmet need for teen-friendly support and information to be available in the public domain, was uncovered by Sanofi. Through market research, Sanofi discovered that teenagers with type 1 diabetes are vulnerable and in a critical adolescent period, dealing with many changes as they move from having their condition largely managed by a guardian to taking control of their diabetes themselves. 

It is critical that control of the condition is achieved at a young age and maintained from diagnosis throughout life. Type 1 diabetes is a lifelong commitment to inject and balance daily insulin doses in order to prevent potentially life-threatening imbalances in blood sugar leading to coma or death in the short term and serious complications that can even result in loss of limbs or eyesight in the long term.

To satisfy this unmet need and improve control of diabetes in young people, Sanofi aims to support type 1 teens to get talking, share their feelings and help them fit diabetes into their life. 

T1DStars was developed at a global level as a platform from which to facilitate dialogue between type 1 teens and the people around them to assist in better managing and understanding their condition.

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics